Find and Pitch Jounalists, Get Your Story Covered

Tags: acute myeloid leukemia, bone marrow, cancer, cell therapy, immunology, NK cells hepatitis leukemia oncology cancer, cancer immunotherapy, cell biology, cell therapy, cytokines, interleukin, tumor microenvironment

	Profile	Recent Articles on Subject
1	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Nouscom reveals promising results for lynch syndrome immunotherapy - 10 days ago Libtayo available in Scotland for cervical cancer patients - about 2 months ago Grifols collaborates with startup FcR Therapeutics to develop autoimmune therapies - 2 months ago Nxera and Cancer Research UK to present promising cancer drug trial at ESMO - 7 months ago
2	Wayne Kuznar MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Using Immune Biomarkers to Guide Treatment in TNBC - 3 months ago No Benefit to Adjuvant-Only Immunotherapy in Early TNBC - over 1 year ago
3	Ryan Haumschild, PharmD, MS, MBA Pharmacy Times Director of Pharmacy. Editorial Board member. Atlanta, Georgia pharmacyhealthcareeditorial workadvisory	Current Landscape of Bispecific Therapies for RRMM - 4 months ago
4	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Myasthenia Gravis: Balancing Traditional Immunotherapies vs Newer Medications - 5 months ago TIL Therapy May Offer Novel Approach for Metastatic Lung Cancer - 9 months ago How to Position the Growing Number of Therapies in IBD - over 1 year ago
5	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Immunotherapy Shows Promise in Downstaging Liver Tumors Prior to Transplant - 5 months ago Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 9 months ago First-Line Immunotherapy Alone Sufficient for Older NSCLC Patients, Study Suggests - about 1 year ago Immunotherapy May Hold Promise for Skin Cancers After Kidney Transplant - about 1 year ago Futile Immunotherapy for Cancer Grows More Common - over 1 year ago Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancer - over 1 year ago
6	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in CAR T-Cell Therapy and Bispecifics for Relapsed/Refractory Multiple Myeloma - 5 months ago Immunotherapy and Chemotherapy Combinations Show Promise for High-Risk HR+/HER2– Breast Cancer - 6 months ago
7	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: Incyte’s checkpoint inhibitor staves off disease progression in anal cancer trial - 7 months ago STAT+: Bristol immunotherapy improves responses in lung cancer, setting up Phase 3 study - 7 months ago STAT+: Lung cancer drug from iTeos, GSK shows response, boosting TIGIT as a viable target - 7 months ago STAT+: FDA approves innovative T cell immunotherapy for rare soft-tissue cancer - 8 months ago STAT+: Study on Amgen’s ‘bispecific’ immunotherapy could lead to approval in small cell lung cancer - over 1 year ago
8	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Expert Discusses Immunotherapy, Antibody Drug Conjugates for Lung Cancer - 7 months ago
9	John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. Healthcare journalism	Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus - 7 months ago CAR-T Treatment Continues to Astonish in Rheumatologic Diseases - 10 months ago
10	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Pharma’s ‘it’ therapy — a new drug class gaining steam - 7 months ago Red Jacket: Helen Sabzevari, an immunotherapy pioneer - over 1 year ago

Journalists covering immunotherapies